Point-of-care diagnosis is a test performed on the site of patient care that provides immediate results.Infectious diseases are caused by various microorganisms, such as viruses, bacteria, fungi and parasites.Instant diagnosis of infectious diseases can improve disease management and detection, reducing the time between disease testing and diagnosis of infection.It also reduces postoperative care time, improves outcomes, improves accuracy of outcomes, and provides a simple way to diagnose infectious diseases, broadly reducing the risk of HIV, tuberculosis, influenza, tropical diseases, and sexually transmitted infections.
This report contains market size and forecasts of Infectious Disease Point of Care Diagnostics in Global, including the following market information:
Global Infectious Disease Point of Care Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Infectious Disease Point of Care Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Over-the-counter (OTC) Testing Kits Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Infectious Disease Point of Care Diagnostics include Abbott, Siemens, GE Healthcare, Accriva, Terumo, BioMerieux, Diasorin, Roche and Danaher Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Infectious Disease Point of Care Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Disease Point of Care Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Infectious Disease Point of Care Diagnostics Market Segment Percentages, by Type, 2021 (%)
Over-the-counter (OTC) Testing Kits
Prescription-based Testing Kits
Global Infectious Disease Point of Care Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Infectious Disease Point of Care Diagnostics Market Segment Percentages, by Application, 2021 (%)
Bacterial Infections
Fungal Infection
Virus Infection
Cardiovascular Infection
Gastrointestinal Infection
Sexually Transmitted Disease (STD) Infection
Central Nervous System Infection
Other
Global Infectious Disease Point of Care Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Infectious Disease Point of Care Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Disease Point of Care Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Infectious Disease Point of Care Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Siemens
GE Healthcare
Accriva
Terumo
BioMerieux
Diasorin
Roche
Danaher Corporation
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
Euroimmun
Gold Standard Diagnostics
Hologic
Immunetics
InBios International